625 related articles for article (PubMed ID: 12714785)
1. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
3. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
Ochi Y; Hamazu M; Kajita Y; Nagata A
Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
[TBL] [Abstract][Full Text] [Related]
6. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
10. Neutralization and purification of thyroid stimulating antibody (TSAb) and thyroid blocking antibody (TBAb) by heterophilic antibody to animal IgG in Graves' disease.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Endocr J; 2012; 59(1):65-72. PubMed ID: 22082836
[TBL] [Abstract][Full Text] [Related]
11. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
[TBL] [Abstract][Full Text] [Related]
12. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
Shibayama K; Ohyama Y; Yokota Y; Ohtsu S; Takubo N; Matsuura N
Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
[TBL] [Abstract][Full Text] [Related]
13. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
[TBL] [Abstract][Full Text] [Related]
14. Immunological similarity of thyroid stimulating antibody (TSAb) and thyroid blocking antibody (TBAb) with animal IgG.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Endocr J; 2012; 59(1):73-9. PubMed ID: 22082835
[TBL] [Abstract][Full Text] [Related]
15. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
Kasagi K; Hatabu H; Tokuda Y; Iida Y; Endo K; Konishi J
Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
[TBL] [Abstract][Full Text] [Related]
16. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
18. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
19. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
[TBL] [Abstract][Full Text] [Related]
20. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K
J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
